Access to the PPM Journal and newsletters is FREE for clinicians.
Signup for PPM

All Post-herpetic Neuralgia Articles

Both pharmacological and non-pharmacological therapies show promising results in patients with shingles.
While Lidoderm is currently FDA-approved only for the pain associated with postherpetic neuralgia (PHN), Phase IV studies suggest that Lidoderm has potential utility in a variety of chronic pain syndromes.
Acute herpes zoster neuritis and postherpetic neuralgia continues to be one of the most painful, acute and chronic conditions to afflict mankind. It will continue to be a major health problem as the baby-boomer generation in the United States ages and is at risk for the reemergence of the varicella zoster virus.
Shingles pain and lesions resolved in 48 hours after treatment with frequency-specific microcurrent. Learn about this non-pharmacologic treatment of shingles.
Laser therapy can be easily and economically used in the treatment of both acute phase herpes zoster and in chronic post-herpetic neuralgia.
A report of three unexplained, severely-disabling pediatric cases, in otherwise healthy children, successfully treated with long term anti-viral therapy.
Article discusses a pain patient that presents with postherpetic neuralgia and multiple musculoskeletal issues, which provides an interesting and challenging case study.
Background, diagnosis, discussion, and case report of successful management of postherpetic neuralgia (PHN) pain in an elderly patient using laser acupuncture.
close X